Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Graco
GGG
$13.3B
| $11.8M | 0.01% |
246,500
+171,400
| +228% | +$8.08M |
|
1127
Wipro
WIT
$19.4B
| $11.8M | 0.01% |
7,134,386
+862,962
| +14% | +$1.35M |
|
1128
Qiagen
QGEN
$8.93B
| $11.8M | 0.01% |
+259,807
| New | +$11.6M |
|
|
MYOV
1129
DELISTED
Myovant Sciences Ltd.
MYOV
| $11.7M | 0.01% |
569,266
+540,566
| +1,884% | +$7.35M |
|
|
CHS
1130
DELISTED
Chicos FAS, Inc.
CHS
| $11.7M | 0.01% |
8,503,100
-647,592
| -7% | -$880K |
|
1131
Arrow Financial
AROW
$723M
| $11.7M | 0.01% |
443,964
-27,350
| -6% | -$669K |
|
1132
Tenet Healthcare
THC
$21.5B
| $11.7M | 0.01% |
645,975
+106,500
| +20% | +$2.1M |
|
1133
Ardelyx
ARDX
$1.01B
| $11.7M | 0.01% |
1,689,334
-298,000
| -15% | -$2.07M |
|
|
DCOM
1134
DELISTED
Dime Community Bancshares
DCOM
| $11.6M | 0.01% |
846,172
-202,400
| -19% | -$2.93M |
|
|
PTNR
1135
DELISTED
Partner Communications
PTNR
| $11.6M | 0.01% |
2,686,551
+901
| +0% | +$3.66K |
|
1136
Hawaiian Electric Industries
HE
$2.04B
| $11.6M | 0.01% |
321,303
+109,300
| +52% | +$4.24M |
|
1137
Mohawk Industries
MHK
$9.27B
| $11.6M | 0.01% |
+113,638
| New | +$10M |
|
1138
Amphastar Pharmaceuticals
AMPH
$858M
| $11.5M | 0.01% |
511,300
-227,300
| -31% | -$4.16M |
|
1139
Popular Inc
BPOP
$11.3B
| $11.5M | 0.01% |
+308,375
| New | +$11.5M |
|
1140
Schwab Short-Term US Treasury ETF
SCHO
$13B
| $11.5M | 0.01% |
443,774
+150,574
| +51% | +$3.89M |
|
1141
Amkor Technology
AMKR
$14.3B
| $11.4M | 0.01% |
928,700
-841,000
| -48% | -$8.68M |
|
1142
IDT Corp
IDT
$1.63B
| $11.4M | 0.01% |
1,745,597
-47,600
| -3% | -$281K |
|
|
SCPL
1143
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $11.4M | 0.01% |
767,600
+706,600
| +1,158% | +$8.67M |
|
1144
NVE Corp
NVEC
$563M
| $11.4M | 0.01% |
184,017
+4,417
| +2% | +$252K |
|
|
PAMT
1145
PAMT Corp
PAMT
$279M
| $11.4M | 0.01% |
1,478,296
-34,400
| -2% | -$287K |
|
1146
Pentair
PNR
$10.5B
| $11.4M | 0.01% |
298,837
+228,173
| +323% | +$8.03M |
|
|
CLDT
1147
Chatham Lodging
CLDT
$590M
| $11.3M | 0.01% |
1,842,276
-261,000
| -12% | -$1.75M |
|
|
PFNX
1148
DELISTED
Pfenex Inc.
PFNX
| $11.3M | 0.01% |
1,349,705
-200,200
| -13% | -$1.5M |
|
1149
Silgan Holdings
SLGN
$4.3B
| $11.3M | 0.01% |
347,680
+21,900
| +7% | +$713K |
|
1150
Peabody Energy
BTU
$2.94B
| $11.3M | 0.01% |
3,906,853
+301,300
| +8% | +$995K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.